F · Healthcare

APTAMER GROUP LTD LS-001 (P0J)

Biotechnology

APTAMER GROUP LTD LS-001 (P0J) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $16.99M, P/E ratio is 18.00, net margin is -178.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for P0J

Market cap
$16.99M
P/E ratio
18.00
Gross profit (TTM)
$672,000
Net margin
-178.5%

APTAMER GROUP LTD LS-001 (P0J) — FAQ

What is APTAMER GROUP LTD LS-001's market cap?

APTAMER GROUP LTD LS-001 (P0J) has a reported market cap of $16.99M (data as of 2026-03-30).

What is P0J's P/E ratio?

The price-to-earnings (P/E) ratio for APTAMER GROUP LTD LS-001 (P0J) is 18.00 (data as of 2026-03-30).

Does APTAMER GROUP LTD LS-001 pay a dividend?

Dividend yield is not available in the current snapshot for APTAMER GROUP LTD LS-001 (P0J). Check the MyAverix Finance app for the latest dividend data.

What sector is APTAMER GROUP LTD LS-001 in?

APTAMER GROUP LTD LS-001 (P0J) is classified in the Healthcare sector (Biotechnology industry).

What exchange is P0J listed on?

P0J is listed on F.

What is APTAMER GROUP LTD LS-001's net margin?

APTAMER GROUP LTD LS-001 (P0J) reports a net margin of -178.5% (data as of 2026-03-30).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play